229 related articles for article (PubMed ID: 24275554)
21. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.
Kehat I; Davis J; Tiburcy M; Accornero F; Saba-El-Leil MK; Maillet M; York AJ; Lorenz JN; Zimmermann WH; Meloche S; Molkentin JD
Circ Res; 2011 Jan; 108(2):176-83. PubMed ID: 21127295
[TBL] [Abstract][Full Text] [Related]
22. Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading.
Divakaran V; Adrogue J; Ishiyama M; Entman ML; Haudek S; Sivasubramanian N; Mann DL
Circ Heart Fail; 2009 Nov; 2(6):633-42. PubMed ID: 19919989
[TBL] [Abstract][Full Text] [Related]
23. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
[TBL] [Abstract][Full Text] [Related]
24. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
[TBL] [Abstract][Full Text] [Related]
25. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
[TBL] [Abstract][Full Text] [Related]
26. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
[TBL] [Abstract][Full Text] [Related]
27. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
28. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
[TBL] [Abstract][Full Text] [Related]
29. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
Jiang DS; Bian ZY; Zhang Y; Zhang SM; Liu Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Hypertension; 2013 Jun; 61(6):1193-202. PubMed ID: 23589561
[TBL] [Abstract][Full Text] [Related]
30. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
31. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
Liu Q; Chen Y; Auger-Messier M; Molkentin JD
Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
[TBL] [Abstract][Full Text] [Related]
32. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload.
Bjørnstad JL; Skrbic B; Marstein HS; Hasic A; Sjaastad I; Louch WE; Florholmen G; Christensen G; Tønnessen T
Cardiovasc Res; 2012 Jan; 93(1):100-10. PubMed ID: 22049534
[TBL] [Abstract][Full Text] [Related]
34. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
35. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
[TBL] [Abstract][Full Text] [Related]
36. Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.
Hua Y; Xu X; Shi GP; Chicco AJ; Ren J; Nair S
Hypertension; 2013 Jun; 61(6):1184-92. PubMed ID: 23529168
[TBL] [Abstract][Full Text] [Related]
37. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
[TBL] [Abstract][Full Text] [Related]
38. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
39. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.
Ruppert C; Deiss K; Herrmann S; Vidal M; Oezkur M; Gorski A; Weidemann F; Lohse MJ; Lorenz K
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7440-5. PubMed ID: 23589880
[TBL] [Abstract][Full Text] [Related]
40. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
